Neogenomics (NEO) Capital Expenditures (QoQ) (2010 - 2026)
Neogenomics (NEO) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.70% |
| Dec 31, 2025 | -309.56% |
| Sep 30, 2025 | 31.49% |
| Jun 30, 2025 | 40.51% |
| Mar 31, 2025 | 115.82% |
| Dec 31, 2024 | -363.45% |
| Sep 30, 2024 | -17.43% |
| Jun 30, 2024 | 134.16% |
| Mar 31, 2024 | 21,580.77% |
| Dec 31, 2023 | 99.85% |
| Sep 30, 2023 | -203.31% |
| Jun 30, 2023 | 1,283.90% |
| Mar 31, 2023 | 104.76% |
| Dec 31, 2022 | -414.50% |
| Sep 30, 2022 | -23.80% |
| Jun 30, 2022 | 25.25% |
| Mar 31, 2022 | -31.43% |
| Dec 31, 2021 | -19.96% |
| Sep 30, 2021 | -57.33% |
| Jun 30, 2021 | 1,586.54% |